CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-26 | Okazaki Jason A Chief Legal & Business Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2020-02-28 | RINGO WILLIAM R Director | Gift | −2,000 | 17,465 | ||
| 2020-01-02 | Small Derek A Director | Grant or award | +125,000 | 828,791 | ||
| 2019-12-13 | Papkoff Jacqueline Sybil SVP-CSO Microbiome | Sale | −1,460 | $21.00 | $31K | 22,915 |
| 2019-12-12 | Colonno Richard James EVP & CSO, Virology Ops | Option exercise | +33,061 | $7.03 | $232K | 160,882 |
| 2019-12-12 | Colonno Richard James EVP & CSO, Virology Ops | Sale | −33,061 | $25.00 | $827K | 127,821 |
| 2019-12-12 | Colonno Richard James EVP & CSO, Virology Ops | Option exercise · Stock Option (right to buy) | −33,061 | 166,939 | ||
| 2019-11-06 | Stamm Luisa M Chief Medical Officer | Grant or award | +12,000 | 12,000 | ||
| 2019-11-06 | Stamm Luisa M Chief Medical Officer | Grant or award · Stock Option (right to buy) | +165,000 | 165,000 | ||
| 2019-10-28 | Russo Thomas Joseph CFO | Grant or award · Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2019-10-01 | Samar Michael P. SVP, Finance and Bus. Ops, PAO | Grant or award | +2,500 | 20,327 | ||
| 2019-10-01 | Samar Michael P. SVP, Finance and Bus. Ops, PAO | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-10-01 | Papkoff Jacqueline Sybil SVP-CSO Microbiome | Grant or award · Stock Options (right to buy) | +27,500 | 27,500 | ||
| 2019-09-28 | McHutchison John G CEO and President | Grant or award · Performance-based Restricted Stock Units | +25,000 | 25,000 | ||
| 2019-08-06 | McHutchison John G CEO and President | Grant or award | +100,000 | 100,000 | ||
| 2019-08-06 | McHutchison John G CEO and President | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2019-05-17 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-17 | Mahony Susan Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-17 | LEWIS ALAN Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-05-17 | Kim Helen Susan Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 12 of 15 · 297 trades